Table of Contents Table of Contents
Previous Page  1720-1721 / 2437 Next Page
Information
Show Menu
Previous Page 1720-1721 / 2437 Next Page
Page Background

PD-1 Inhibitor Pembrolizumab

NSCLC and melanoma brain metastases

Goldberg S.

Lancet Oncol 2016